PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
LKE | Ann: Results of Share Purchase Plan | 10:41 | 58 | 8.5K | |||
|
|||||||
LKE | Ann: Application for quotation of securities - LKE | 08:58 | 0 | 184 | |||
|
|||||||
LKE | LKE towards TOP-5 | 23/04/24 | 24K | 6.4M | |||
|
|||||||
LKE | Ann: Reminder of Closing Date for Share Purchase Plan | 23/04/24 | 97 | 19K | |||
|
|||||||
LKE | LKE 2.0 | 23/04/24 | 1.8K | 309K | |||
|
|||||||
LKE | Is the bottom in? | 21/04/24 | 1.2K | 234K | |||
|
|||||||
LKE | Ann: Extension of Share Purchase Plan and ASX Waiver | 13/04/24 | 130 | 33K | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |